---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-21-132980"
form_type: "8-K"
ticker: "TRDA"
cik: "0001689375"
company_name: "Entrada Therapeutics, Inc."
filed_at: "2021-11-02T23:59:59+00:00"
generated_at: "2026-06-28T15:15:02.639235+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Entrada Therapeutics files amended charter and bylaws in connection with IPO

## Summary
- Authorizes 150M shares of common stock and 10M shares of undesignated preferred stock.
- Bylaws eliminate stockholder action by written consent, set procedures for proposals and nominations.
- Changes previously disclosed in S-1; effective upon IPO consummation on November 2, 2021.

## SEC filing metadata
- accession: 0001104659-21-132980
- form_type: 8-K
- ticker: TRDA
- cik: 0001689375
- company_name: Entrada Therapeutics, Inc.
- filed_at: 2021-11-02T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1689375/000110465921132980/0001104659-21-132980-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1689375/000110465921132980/tm2131671d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-21-132980
- JSON: https://secwatch.observer/filing/0001104659-21-132980.json
- Plain text: https://secwatch.observer/filing/0001104659-21-132980.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.